LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC
16 Mars 202528min
Virtual Tumor Board: Targeting Residual Disease
Virtual Tumor Board: Targeting Residual Disease by IASLC
16 Mars 202549min
LCC in Korean: 2024 Lung Cancer Updates
LCC in Korean: 2024 Lung Cancer Updates by IASLC
16 Mars 202533min
Live from TTLC25: Lung Cancer and Brain Metastasis
Live from TTLC25: Lung Cancer and Brain Metastasis by IASLC
15 Mars 202519min
Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC
Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine Guest: Saadettin Kilickap Guest: Ozden Altundag
15 Mars 202556min
Thymus Talk: Unraveling Thymoma and Thymic Carcinoma
This episode of Lung Cancer Considered takes an in-depth look at thymoma and thymic carcinomas, both challenging diseases to treat with evolving new therapeutics. Join host Dr. Narjust Florez and gues...
15 Mars 202545min
Lung Cancer Considered in Hungarian: Lung Cancer Treatment Updates
As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc Rényi-Vámos and Dr. Zsolt Megyesfalvi. The ...
14 Mars 20251h 1min
LCC in Cantonese: WCLC24 Highlights
The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversa...
9 Mars 202525min
